190 related articles for article (PubMed ID: 31287662)
1. Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles.
Sauvage F; Fraire JC; Remaut K; Sebag J; Peynshaert K; Harrington M; Van de Velde FJ; Xiong R; Tassignon MJ; Brans T; Braeckmans K; De Smedt SC
ACS Nano; 2019 Jul; 13(7):8401-8416. PubMed ID: 31287662
[TBL] [Abstract][Full Text] [Related]
2. Laser-induced nanobubbles safely ablate vitreous opacities in vivo.
Sauvage F; Nguyen VP; Li Y; Harizaj A; Sebag J; Roels D; Van Havere V; Peynshaert K; Xiong R; Fraire JC; Tassignon MJ; Remaut K; Paulus YM; Braeckmans K; De Smedt SC
Nat Nanotechnol; 2022 May; 17(5):552-559. PubMed ID: 35302088
[TBL] [Abstract][Full Text] [Related]
3. Vitreous and Vision Degrading Myodesopsia.
Sebag J
Prog Retin Eye Res; 2020 Nov; 79():100847. PubMed ID: 32151758
[TBL] [Abstract][Full Text] [Related]
4. [Vitreous floaters].
Schmitz-Valckenberg S; Brasse K; Hoerauf H
Ophthalmologe; 2020 May; 117(5):485-496. PubMed ID: 32291480
[TBL] [Abstract][Full Text] [Related]
5. Carbon quantum dots as a dual platform for the inhibition and light-based destruction of collagen fibers: implications for the treatment of eye floaters.
Barras A; Sauvage F; de Hoon I; Braeckmans K; Hua D; Buvat G; Fraire JC; Lethien C; Sebag J; Harrington M; Abderrahmani A; Boukherroub R; De Smedt S; Szunerits S
Nanoscale Horiz; 2021 Jun; 6(6):449-461. PubMed ID: 33903870
[TBL] [Abstract][Full Text] [Related]
6. Vitreous floaters: Etiology, diagnostics, and management.
Milston R; Madigan MC; Sebag J
Surv Ophthalmol; 2016; 61(2):211-27. PubMed ID: 26679984
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
Katsanos A; Tsaldari N; Gorgoli K; Lalos F; Stefaniotou M; Asproudis I
Adv Ther; 2020 Apr; 37(4):1319-1327. PubMed ID: 32086749
[TBL] [Abstract][Full Text] [Related]
8. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
Singh IP
Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
[TBL] [Abstract][Full Text] [Related]
9. [YAG laser vitreolysis for treatment of symptomatic vitreous opacities].
Brasse K; Schmitz-Valckenberg S; Jünemann A; Roider J; Hoerauf H
Ophthalmologe; 2019 Jan; 116(1):73-84. PubMed ID: 30203171
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.
Hangshuai Z; Yanhua J; Yao Z; Guangjin Z; Hongyan W; Fanlian C
Trials; 2024 Jan; 25(1):48. PubMed ID: 38218919
[TBL] [Abstract][Full Text] [Related]
11. Practical applications of vitreous imaging for the treatment of vitreous opacities with YAG vitreolysis.
Jiang S; Golding J; Choudhry N
Int Ophthalmol; 2023 Oct; 43(10):3587-3594. PubMed ID: 37402010
[TBL] [Abstract][Full Text] [Related]
12. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
Su D; Shah CP; Hsu J
Surv Ophthalmol; 2020; 65(5):589-591. PubMed ID: 32135173
[TBL] [Abstract][Full Text] [Related]
13. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
Vandorselaer T; Van De Velde F; Tassignon MJ
Bull Soc Belge Ophtalmol; 2001; (280):15-9. PubMed ID: 11486460
[TBL] [Abstract][Full Text] [Related]
14. Current treatment strategies for symptomatic vitreous opacities.
Ryan EH
Curr Opin Ophthalmol; 2021 May; 32(3):198-202. PubMed ID: 33710011
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution.
Apaolaza PS; Busch M; Asin-Prieto E; Peynshaert K; Rathod R; Remaut K; Dünker N; Göpferich A
Exp Eye Res; 2020 Sep; 198():108151. PubMed ID: 32721426
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.
Ivanova T; Jalil A; Antoniou Y; Bishop PN; Vallejo-Garcia JL; Patton N
Eye (Lond); 2016 May; 30(5):645-55. PubMed ID: 26939559
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy for persistent, visually significant vitreous opacities.
Schiff WM; Chang S; Mandava N; Barile GR
Retina; 2000; 20(6):591-6. PubMed ID: 11131410
[TBL] [Abstract][Full Text] [Related]
18. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
Shah CP; Heier JS
JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gold nanoparticle mediated photoporation: vapor nanobubbles outperform direct heating for delivering macromolecules in live cells.
Xiong R; Raemdonck K; Peynshaert K; Lentacker I; De Cock I; Demeester J; De Smedt SC; Skirtach AG; Braeckmans K
ACS Nano; 2014 Jun; 8(6):6288-96. PubMed ID: 24870061
[TBL] [Abstract][Full Text] [Related]
20. Vitrectomy for large vitreous opacity in retinitis pigmentosa.
Hong PH; Han DP; Burke JM; Wirostko WJ
Am J Ophthalmol; 2001 Jan; 131(1):133-4. PubMed ID: 11162992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
